PERCEPTIVE ADVISORS LLC has filed 96 insider transactions across 12 companies since May 2023.
Most recent transaction: a grant/award of 8912655 shares of Solid Biosciences Inc. ($SLDB) on March 09, 2026.
Activity breakdown: 50 open-market purchases and 20 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | Solid Biosciences Inc. | $SLDB | PERCEPTIVE ADVISORS LLC | Not found | A | Pre-Funded Warrant (right to buy) | 8912655 | $5.61 | 8,912,655.0000 | 94,417,746 | 9999.99% | 9.44% |
| Dec. 31, 2025 | MeiraGTx Holdings plc | $MGTX | PERCEPTIVE ADVISORS LLC | Not found | D | Ordinary Shares | 2300000 | $7.91 | 10,231,103.0000 | 80,947,703 | 18.35% | 2.84% |
| Dec. 23, 2025 | LeonaBio, Inc. | $LONA | PERCEPTIVE ADVISORS LLC | Director | A | Common Stock | 989270 | $6.35 | 1,529,566.0000 | 3,943,887 | 183.10% | 25.08% |
| Dec. 23, 2025 | LeonaBio, Inc. | $LONA | PERCEPTIVE ADVISORS LLC | Director | A | Pre-Funded Warrant (right to buy) | 5502402 | $0.00 | 5,502,402.0000 | 3,943,887 | 9999.99% | 100.00% |
| Dec. 23, 2025 | LeonaBio, Inc. | $LONA | PERCEPTIVE ADVISORS LLC | Director | A | Series B Warrant (right to buy) | 1181101 | $6.35 | 1,181,101.0000 | 3,943,887 | 9999.99% | 29.95% |
| Dec. 23, 2025 | LeonaBio, Inc. | $LONA | PERCEPTIVE ADVISORS LLC | Director | A | Series A Warrant (right to buy) | 1279526 | $6.35 | 1,279,526.0000 | 3,943,887 | 9999.99% | 32.44% |
| Dec. 23, 2025 | LeonaBio, Inc. | $LONA | PERCEPTIVE ADVISORS LLC | Director | A | Pre-Funded Warrant (right to buy) | 457645 | $6.35 | 457,645.0000 | 3,943,887 | 9999.99% | 11.60% |
| Dec. 23, 2025 | LeonaBio, Inc. | $LONA | PERCEPTIVE ADVISORS LLC | Director | A | Series B Warrant (right to buy) | 3543307 | $6.35 | 3,543,307.0000 | 3,943,887 | 9999.99% | 89.84% |
| Dec. 23, 2025 | LeonaBio, Inc. | $LONA | PERCEPTIVE ADVISORS LLC | Director | A | Pre-Funded Warrant (right to buy) | 1372935 | $6.35 | 1,372,935.0000 | 3,943,887 | 9999.99% | 34.81% |
| Dec. 23, 2025 | LeonaBio, Inc. | $LONA | PERCEPTIVE ADVISORS LLC | Director | A | Series A Warrant (right to buy) | 3838583 | $6.35 | 3,838,583.0000 | 3,943,887 | 9999.99% | 97.33% |
| Dec. 23, 2025 | LeonaBio, Inc. | $LONA | PERCEPTIVE ADVISORS LLC | Director | A | Common Stock | 329756 | $6.35 | 329,756.0000 | 3,943,887 | 9999.99% | 8.36% |
| Nov. 13, 2025 | Lyra Therapeutics, Inc. | $LYRA | PERCEPTIVE ADVISORS LLC | Not found | S | Common Stock | 28597 | $3.90 | 124,859.0000 | 1,774,882 | 18.64% | 1.61% |
| Nov. 12, 2025 | Lyra Therapeutics, Inc. | $LYRA | PERCEPTIVE ADVISORS LLC | Not found | S | Common Stock | 7862 | $4.06 | 153,456.0000 | 1,774,882 | 4.87% | 0.44% |
| Nov. 11, 2025 | Lyra Therapeutics, Inc. | $LYRA | PERCEPTIVE ADVISORS LLC | Not found | S | Common Stock | 537 | $4.31 | 18,122.0000 | 1,774,882 | 2.88% | 0.03% |
| Nov. 11, 2025 | Lyra Therapeutics, Inc. | $LYRA | PERCEPTIVE ADVISORS LLC | Not found | S | Common Stock | 4783 | $4.31 | 161,318.0000 | 1,774,882 | 2.88% | 0.27% |
| Nov. 13, 2025 | Lyra Therapeutics, Inc. | $LYRA | PERCEPTIVE ADVISORS LLC | Not found | S | Common Stock | 3213 | $3.90 | 14,026.0000 | 1,774,882 | 18.64% | 0.18% |
| Nov. 12, 2025 | Lyra Therapeutics, Inc. | $LYRA | PERCEPTIVE ADVISORS LLC | Not found | S | Common Stock | 883 | $4.06 | 17,239.0000 | 1,774,882 | 4.87% | 0.05% |
| Nov. 10, 2025 | Lyra Therapeutics, Inc. | $LYRA | PERCEPTIVE ADVISORS LLC | Not found | S | Common Stock | 16633 | $4.54 | 166,101.0000 | 1,774,882 | 9.10% | 0.94% |
| Nov. 6, 2025 | Lyra Therapeutics, Inc. | $LYRA | PERCEPTIVE ADVISORS LLC | Not found | S | Common Stock | 28902 | $5.18 | 200,480.0000 | 65,880,561 | 12.60% | 0.04% |
| Nov. 6, 2025 | Lyra Therapeutics, Inc. | $LYRA | PERCEPTIVE ADVISORS LLC | Not found | S | Common Stock | 3247 | $5.18 | 22,521.0000 | 65,880,561 | 12.60% | 0.00% |
| Nov. 7, 2025 | Lyra Therapeutics, Inc. | $LYRA | PERCEPTIVE ADVISORS LLC | Not found | S | Common Stock | 17746 | $4.75 | 182,734.0000 | 65,880,561 | 8.85% | 0.03% |
| Nov. 10, 2025 | Lyra Therapeutics, Inc. | $LYRA | PERCEPTIVE ADVISORS LLC | Not found | S | Common Stock | 1869 | $4.54 | 18,659.0000 | 1,774,882 | 9.10% | 0.11% |
| Nov. 7, 2025 | Lyra Therapeutics, Inc. | $LYRA | PERCEPTIVE ADVISORS LLC | Not found | S | Common Stock | 1993 | $4.75 | 20,528.0000 | 65,880,561 | 8.85% | 0.00% |
| Oct. 20, 2025 | Adagio Medical Holdings, Inc. | $ADGM | PERCEPTIVE ADVISORS LLC | Not found | P | Tranche A Warrant ("Common Warrant" right to buy) | 1344999 | $0.18 | 1,344,999.0000 | 15,381,565 | 9999.99% | 8.74% |
| Oct. 20, 2025 | Adagio Medical Holdings, Inc. | $ADGM | PERCEPTIVE ADVISORS LLC | Not found | P | Pre-Funded Warrant (right to buy) | 2190496 | $1.60 | 2,190,496.0000 | 15,381,565 | 9999.99% | 14.24% |
| Oct. 20, 2025 | Adagio Medical Holdings, Inc. | $ADGM | PERCEPTIVE ADVISORS LLC | Not found | P | Tranche C Warrant ("Common Warrant" right to buy) | 1344999 | $0.18 | 1,344,999.0000 | 15,381,565 | 9999.99% | 8.74% |
| Oct. 20, 2025 | Adagio Medical Holdings, Inc. | $ADGM | PERCEPTIVE ADVISORS LLC | Not found | P | Tranche B Warrant ("Common Warrant" right to buy) | 1344999 | $0.18 | 1,344,999.0000 | 15,381,565 | 9999.99% | 8.74% |
| Aug. 1, 2025 | Orchestra BioMed Holdings, Inc. | $OBIO | PERCEPTIVE ADVISORS LLC | Not found | P | Pre-funded Warrants (right to buy) | 1500000 | $2.75 | 1,500,000.0000 | 38,392,716 | 9999.99% | 3.91% |
| Aug. 1, 2025 | Orchestra BioMed Holdings, Inc. | $OBIO | PERCEPTIVE ADVISORS LLC | Not found | P | Common Stock | 700000 | $2.75 | 5,292,556.0000 | 38,392,716 | 15.24% | 1.82% |
| June 12, 2025 | MeiraGTx Holdings plc | $MGTX | PERCEPTIVE ADVISORS LLC | Director | A | Restricted Share Units | 45000 | $0.00 | 45,000.0000 | 79,032,341 | 9999.99% | 0.06% |
| June 12, 2025 | Solid Biosciences Inc. | $SLDB | PERCEPTIVE ADVISORS LLC | Director | A | Director Stock Option (Right to Buy) | 77500 | $0.00 | 77,500.0000 | 40,816,694 | 9999.99% | 0.19% |
| April 30, 2025 | Acrivon Therapeutics, Inc. | $ACRV | PERCEPTIVE ADVISORS LLC | TenPercentOwner | S | Common Stock | 437881 | $1.41 | 3,403,025.0000 | 33,791,817 | 11.40% | 1.30% |
| May 1, 2025 | Acrivon Therapeutics, Inc. | $ACRV | PERCEPTIVE ADVISORS LLC | TenPercentOwner | S | Common Stock | 298886 | $1.34 | 3,104,139.0000 | 33,791,817 | 8.78% | 0.88% |
| April 25, 2025 | Acrivon Therapeutics, Inc. | $ACRV | PERCEPTIVE ADVISORS LLC | TenPercentOwner | S | Common Stock | 1054669 | $1.95 | 4,306,189.0000 | 33,791,817 | 19.67% | 3.12% |
| April 29, 2025 | Acrivon Therapeutics, Inc. | $ACRV | PERCEPTIVE ADVISORS LLC | TenPercentOwner | S | Common Stock | 250000 | $1.41 | 3,840,906.0000 | 33,791,817 | 6.11% | 0.74% |
| April 28, 2025 | Acrivon Therapeutics, Inc. | $ACRV | PERCEPTIVE ADVISORS LLC | TenPercentOwner | S | Common Stock | 215283 | $1.56 | 4,090,906.0000 | 33,791,817 | 5.00% | 0.64% |
| April 3, 2025 | Aldeyra Therapeutics, Inc. | $ALDX | PERCEPTIVE ADVISORS LLC | TenPercentOwner | S | Common Stock | 3400000 | $1.42 | 5,875,851.0000 | 59,708,654 | 36.65% | 5.69% |
| Feb. 19, 2025 | Solid Biosciences Inc. | $SLDB | PERCEPTIVE ADVISORS LLC | Director | P | Common Stock | 5000000 | $4.03 | 11,906,646.0000 | 40,816,694 | 72.39% | 12.25% |
| Jan. 22, 2025 | Adagio Medical Holdings, Inc. | $ADGM | PERCEPTIVE ADVISORS LLC | Director | A | Common Stock | 64167 | $0.00 | 9,876,586.0000 | 14,772,692 | 0.65% | 0.43% |
| June 11, 2024 | Solid Biosciences Inc. | $SLDB | PERCEPTIVE ADVISORS LLC | Director | A | Director Stock Option (Right to Buy) | 34400 | $0.00 | 34,400.0000 | 19,884,007 | 9999.99% | 0.17% |
| Aug. 12, 2024 | MeiraGTx Holdings plc | $MGTX | PERCEPTIVE ADVISORS LLC | Director | P | Ordinary Shares | 1250000 | $4.00 | 12,531,103.0000 | 64,376,396 | 11.08% | 1.94% |
| June 14, 2024 | Nautilus Biotechnology, Inc. | $NAUT | PERCEPTIVE ADVISORS LLC | Director | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2024 | MeiraGTx Holdings plc | $MGTX | PERCEPTIVE ADVISORS LLC | Director | A | Restricted Share Units | 45000 | $0.00 | 45,000.0000 | 64,065,895 | 9999.99% | 0.07% |
| April 11, 2024 | Acrivon Therapeutics, Inc. | $ACRV | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 2353000 | $8.50 | 5,360,858.0000 | 22,078,190 | 78.23% | 10.66% |
| April 5, 2024 | Aldeyra Therapeutics, Inc. | $ALDX | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 37712 | $4.74 | 9,275,851.0000 | 0 | 0.41% | 0.00% |
| April 4, 2024 | Aldeyra Therapeutics, Inc. | $ALDX | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 140281 | $4.67 | 9,238,139.0000 | 0 | 1.54% | 0.00% |
| April 2, 2024 | Aldeyra Therapeutics, Inc. | $ALDX | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 186051 | $3.44 | 8,788,011.0000 | 0 | 2.16% | 0.00% |
| April 1, 2024 | Aldeyra Therapeutics, Inc. | $ALDX | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 8374 | $3.25 | 8,601,960.0000 | 0 | 0.10% | 0.00% |
| April 3, 2024 | Aldeyra Therapeutics, Inc. | $ALDX | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 309847 | $4.09 | 9,097,858.0000 | 0 | 3.53% | 0.00% |
| Feb. 15, 2024 | LianBio | $LIANY | PERCEPTIVE ADVISORS LLC | Director | F | Ordinary Shares | 19218 | $4.76 | 53,847,042.0000 | 107,167,691 | 0.04% | 0.02% |
| Feb. 15, 2024 | LianBio | $LIANY | PERCEPTIVE ADVISORS LLC | Director | M | Stock Option (Right to Buy) | 36300 | $0.00 | 0.0000 | 107,167,691 | 100.00% | 0.03% |
| Feb. 15, 2024 | LianBio | $LIANY | PERCEPTIVE ADVISORS LLC | Director | M | Stock Option (Right to Buy) | 36300 | $0.00 | 0.0000 | 107,167,691 | 100.00% | 0.03% |
| Feb. 15, 2024 | LianBio | $LIANY | PERCEPTIVE ADVISORS LLC | Director | F | Ordinary Shares | 19218 | $4.76 | 53,847,042.0000 | 107,167,691 | 0.04% | 0.02% |
| Feb. 15, 2024 | LianBio | $LIANY | PERCEPTIVE ADVISORS LLC | Director | M | Ordinary Shares | 36300 | $2.52 | 53,866,260.0000 | 107,167,691 | 0.07% | 0.03% |
| Feb. 15, 2024 | LianBio | $LIANY | PERCEPTIVE ADVISORS LLC | Director | M | Ordinary Shares | 36300 | $2.52 | 53,866,260.0000 | 107,167,691 | 0.07% | 0.03% |
| Feb. 1, 2024 | Astria Therapeutics, Inc. | $ATXS | PERCEPTIVE ADVISORS LLC | Director | P | Common Stock | 2481350 | $12.09 | 6,485,420.0000 | 30,123,316 | 61.97% | 8.24% |
| Jan. 11, 2024 | Solid Biosciences Inc. | $SLDB | PERCEPTIVE ADVISORS LLC | Director | P | Common Stock | 3410713 | $5.53 | 6,906,646.0000 | 19,884,007 | 97.56% | 17.15% |
| Dec. 29, 2023 | LeonaBio, Inc. | $LONA | PERCEPTIVE ADVISORS LLC | Director | P | Common Stock | 163954 | $2.38 | 5,402,964.0000 | 0 | 3.13% | 0.00% |
| Dec. 28, 2023 | LeonaBio, Inc. | $LONA | PERCEPTIVE ADVISORS LLC | Director | P | Common Stock | 409598 | $2.44 | 5,239,010.0000 | 0 | 8.48% | 0.00% |
| Dec. 27, 2023 | LeonaBio, Inc. | $LONA | PERCEPTIVE ADVISORS LLC | Director | P | Common Stock | 32134 | $2.28 | 4,829,412.0000 | 0 | 0.67% | 0.00% |
| Oct. 16, 2023 | Aldeyra Therapeutics, Inc. | $ALDX | PERCEPTIVE ADVISORS LLC | TenPercentOwner | S | Common Stock | 2450000 | $1.60 | 8,900,085.0000 | 0 | 21.59% | 0.00% |
| Oct. 18, 2023 | Aldeyra Therapeutics, Inc. | $ALDX | PERCEPTIVE ADVISORS LLC | TenPercentOwner | S | Common Stock | 306499 | $1.74 | 8,593,586.0000 | 0 | 3.44% | 0.00% |
| Sept. 26, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 27769 | $16.00 | 2,452,754.0000 | 8,397,088 | 1.15% | 0.33% |
| Sept. 26, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 5703 | $7.65 | 2,213,456.0000 | 8,397,088 | 0.26% | 0.07% |
| Sept. 26, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 13687 | $8.30 | 2,227,143.0000 | 8,397,088 | 0.62% | 0.16% |
| Sept. 26, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 5419 | $9.52 | 2,232,562.0000 | 8,397,088 | 0.24% | 0.06% |
| Sept. 26, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 37911 | $11.05 | 2,270,473.0000 | 8,397,088 | 1.70% | 0.45% |
| Sept. 26, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 77837 | $11.81 | 2,348,310.0000 | 8,397,088 | 3.43% | 0.93% |
| Sept. 26, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 42838 | $12.84 | 2,391,148.0000 | 8,397,088 | 1.82% | 0.51% |
| Sept. 26, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 30511 | $13.92 | 2,421,659.0000 | 8,397,088 | 1.28% | 0.36% |
| Sept. 26, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 3326 | $14.61 | 2,424,985.0000 | 8,397,088 | 0.14% | 0.04% |
| Sept. 26, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 75477 | $17.28 | 2,528,231.0000 | 8,397,088 | 3.08% | 0.90% |
| Sept. 26, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 52691 | $18.24 | 2,580,922.0000 | 8,397,088 | 2.08% | 0.63% |
| Sept. 26, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 88685 | $19.11 | 2,669,607.0000 | 8,397,088 | 3.44% | 1.06% |
| Sept. 26, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 117996 | $20.03 | 2,787,603.0000 | 8,397,088 | 4.42% | 1.41% |
| Sept. 26, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 36939 | $21.00 | 2,824,542.0000 | 8,397,088 | 1.33% | 0.44% |
| Sept. 28, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 250000 | $20.00 | 3,074,542.0000 | 8,397,088 | 8.85% | 2.98% |
| Sept. 28, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Pre-funded warrants (right to buy) | 250000 | $19.99 | 250,000.0000 | 8,397,088 | 9999.99% | 2.98% |
| June 15, 2023 | Nautilus Biotechnology, Inc. | $NAUT | PERCEPTIVE ADVISORS LLC | Director | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | MeiraGTx Holdings plc | $MGTX | PERCEPTIVE ADVISORS LLC | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 48,638,151 | 9999.99% | 0.04% |
| June 8, 2023 | MeiraGTx Holdings plc | $MGTX | PERCEPTIVE ADVISORS LLC | Director | A | Restricted Share Units | 20000 | $0.00 | 20,000.0000 | 48,638,151 | 9999.99% | 0.04% |
| June 5, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 78468 | $5.98 | 2,207,553.0000 | 8,397,088 | 3.69% | 0.93% |
| June 2, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 64630 | $5.93 | 2,129,085.0000 | 8,397,088 | 3.13% | 0.77% |
| June 6, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 200 | $5.93 | 2,207,753.0000 | 8,397,088 | 0.01% | 0.00% |
| May 31, 2023 | Lyra Therapeutics, Inc. | $LYRA | PERCEPTIVE ADVISORS LLC | Director | P | Common Stock Purchase Warrant | 1805416 | $0.00 | 1,805,416.0000 | 0 | 9999.99% | 0.00% |
| May 31, 2023 | Lyra Therapeutics, Inc. | $LYRA | PERCEPTIVE ADVISORS LLC | Director | P | Common Stock | 3610832 | $2.49 | 12,757,563.0000 | 0 | 39.48% | 0.00% |
| June 1, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 7500 | $5.59 | 2,064,455.0000 | 8,397,088 | 0.36% | 0.09% |
| May 31, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 10000 | $5.28 | 2,056,955.0000 | 8,397,088 | 0.49% | 0.12% |
| May 30, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 17500 | $5.34 | 2,046,955.0000 | 8,397,088 | 0.86% | 0.21% |
| May 26, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | 210859 | 22500 | $5.27 | 2,029,455.0000 | 8,397,088 | 1.12% | 0.27% |
| May 24, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | 210859 | 25000 | $5.48 | 1,969,455.0000 | 8,397,088 | 1.29% | 0.30% |
| May 25, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | 210859 | 37500 | $5.18 | 2,006,955.0000 | 8,397,088 | 1.90% | 0.45% |
| May 23, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 27500 | $5.45 | 1,944,455.0000 | 8,397,088 | 1.43% | 0.33% |
| May 22, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 27300 | $5.12 | 1,916,955.0000 | 8,397,088 | 1.44% | 0.33% |
| May 19, 2023 | SOLENO THERAPEUTICS INC | $SLNO | PERCEPTIVE ADVISORS LLC | TenPercentOwner | P | Common Stock | 25200 | $4.62 | 1,889,655.0000 | 8,397,088 | 1.35% | 0.30% |
| May 5, 2023 | MeiraGTx Holdings plc | $MGTX | PERCEPTIVE ADVISORS LLC | Director | P | Ordinary Shares | 4347826 | $5.75 | 11,281,103.0000 | 48,638,151 | 62.71% | 8.94% |